Having already teamed up with other market leaders in the areas of surgery and diabetes, Alphabet's health unit Verily Life Sciences LLC is now targeting the sleep disorder space and teaming up with leading sleep company ResMed Inc. to form a joint venture focused on sleep apnea treatments and connected health products. In particular, the JV aims to develop software solutions that enable health care providers to better diagnose, treat and manage sleep apnea and other breathing-related sleep disorders.
Financial details of the agreement were not revealed. However, sleep apnea is a potentially serious disorder that affects an estimated 54 million Americans alone, according to ResMed. And its societal...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?